During the past decade, Center for Sight conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Center for Sight" are "Keratoconus" (2 trials), "Corneal Ectasia" (1 trials) and "Ectasia" (1 trials). Many other conditions were trialed in "Center for Sight" in a lesser frequency.

Most popular intervention types in "Center for Sight" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "KXL System (15 mW/cm2)" (1 trials), "KXL System (30 mW/cm2)" (1 trials), "KXL System (45 mW/cm2)" (1 trials), "Ricrolin+" (1 trials) and "VEGA UV-A system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Sight" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Center for Sight". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Center for Sight, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Sight, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".